berberine has been researched along with s-allylcysteine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chowdhury, KD; Paul, S; Sadhukhan, GC; Sarkar, A; Sengupta, D | 1 |
Chatterjee, S; Chowdhury, KD; Paul, S; Sadhukhan, GC; Sarkar, A; Sengupta, D; Sur, PK | 1 |
2 other study(ies) available for berberine and s-allylcysteine
Article | Year |
---|---|
Berberine and S allyl cysteine mediated amelioration of DEN+CCl4 induced hepatocarcinoma.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Apoptosis; Berberine; Blotting, Western; Carbon Tetrachloride; Carcinoma, Hepatocellular; Caspase 3; Cells, Cultured; Cysteine; Cytochrome P-450 CYP2E1; Cytochromes c; Diethylnitrosamine; Flow Cytometry; Hepatocytes; Histone Deacetylase 1; Immunoenzyme Techniques; Immunoprecipitation; Liver Neoplasms; Male; Membrane Potential, Mitochondrial; Mice; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Oxidative Stress; Reactive Oxygen Species | 2014 |
Modulation of adenylate cyclase signaling in association with MKK3/6 stabilization under combination of SAC and berberine to reduce HepG2 cell survivability.
Topics: Adenylyl Cyclases; Apoptosis; Apoptosis Inducing Factor; Berberine; BH3 Interacting Domain Death Agonist Protein; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 8; Cell Line; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cysteine; DNA Fragmentation; Drug Combinations; Gene Expression Regulation; Hep G2 Cells; Humans; Leukocytes, Mononuclear; MAP Kinase Kinase 3; MAP Kinase Kinase 6; Necrosis; NF-kappa B; Nuclear Pore Complex Proteins; Protein Transport; RNA-Binding Proteins; Signal Transduction; Tumor Suppressor Protein p53 | 2017 |